T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy

Front Immunol. 2022 Sep 23:13:977394. doi: 10.3389/fimmu.2022.977394. eCollection 2022.

Abstract

Immune-mediated inflammatory diseases(IMIDs) are referred to as highly disabling chronic diseases affecting different organs and systems. Inappropriate or excessive immune responses with chronic inflammation are typical manifestations. Usually in patients with chronic infection and cancer, due to long-term exposure to persistent antigens and inflammation microenvironment, T-cells are continuously stimulated and gradually differentiate into an exhausted state. Exhausted T-cells gradually lose effector function and characteristics of memory T-cells. However, existing studies have found that exhausted T-cells are not only present in the infection and tumor environment, but also in autoimmunity, and are associated with better prognosis of IMIDs. This suggests new prospects for the application of this reversible process of T-cell exhaustion in the treatment of IMID. This review will focus on the research progress of T-cell exhaustion in several IMIDs and its potential application for diagnosis and treatment in IMIDs.

Keywords: T-cell exhaustion; autoimmunity; immune-mediated inflammatory diseases(IMIDs); immunotherapy; inhibitory receptor; therapeutic exhaustion.

Publication types

  • Review

MeSH terms

  • Autoimmunity
  • Humans
  • Immunologic Factors
  • Immunotherapy*
  • Inflammation
  • Neoplasms* / therapy
  • Tumor Microenvironment

Substances

  • Immunologic Factors